Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2002-04-17 Report Publication Anno…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
延期披露2001年年度报告
Report Publication Announcement Classification · 100% confidence The document is a short announcement from Shanghai Wangchunhua (Group) Co., Ltd. stating that the disclosure of the 2001 annual report is delayed from April 20, 2002, to April 26, 2002. It does not contain the actual annual report or financial data but merely informs about the postponement of the report's release. The document length is only 498 characters, indicating it is a brief notice rather than a full report. According to the 'Menu vs Meal' rule, such a short announcement about report timing is classified as a Report Publication Announcement (RPA).
2002-04-17 Chinese
延期披露2001年年度报告
Report Publication Announcement Classification · 100% confidence The document is a short announcement from Shanghai Wangchunhua (Group) Co., Ltd. stating that the disclosure of the 2001 annual report is delayed from April 20, 2002, to April 26, 2002. It does not contain the actual annual report or financial data but merely informs about the postponement of the report's release. The document length is only 498 characters, indicating it is a brief notice rather than a full report. According to the 'MENU VS MEAL' rule, such a short announcement about report timing is classified as a Report Publication Announcement (RPA).
2002-04-16 Chinese
转让承德祥业路桥建设有限公司股权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the transfer of a 40% equity stake in a subsidiary company (承德祥业路桥建设有限公司) by 上海望春花（集团）股份有限公司 to another company. It details the transaction terms, parties involved, pricing, and the strategic rationale behind the sale. There are no financial statements or comprehensive financial performance data included, nor is this a report or presentation. The document is a formal announcement of a capital transaction involving share transfer, which fits the category of Capital/Financing Update (CAP). The document length is 2662 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is CAP with high confidence.
2002-04-01 Chinese
2001年度业绩预警公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (585 characters) titled '2001年度业绩预警公告' which translates to '2001 Annual Performance Warning Announcement'. It states that the company's 2001 annual performance is expected to decline significantly and that final audited data will be disclosed in the 2001 annual report. The document does not contain actual financial statements or detailed financial data but is a warning or alert about expected performance. It is not the full annual report itself but an announcement related to the upcoming report. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory announcement about expected financial results without substantive financial data.
2002-01-25 Chinese
通过了总经理工作细则等
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the board of directors and supervisory board meetings of Shanghai Wangchunhua (Group) Co., Ltd. It includes approval of the General Manager's work rules, changes in accounting methods for bad debt provisions, termination of a securities investment advisory agreement, and a detailed rectification report following a regulatory inspection by the China Securities Regulatory Commission Shanghai Office. The document contains no financial statements or comprehensive financial data but focuses on governance, compliance, and management decisions. It is not a full annual or interim report, nor an earnings release or audit report. The content aligns with Board/Management Information (MANG) as it announces board resolutions and management decisions. The document length is about 4658 characters, sufficient for a detailed announcement but not a full report. Therefore, the classification is MANG with high confidence.
2002-01-14 Chinese
澄清公告
Regulatory Filings Classification · 95% confidence The document is a clarification announcement by Shanghai Wangchunhua (Group) Co., Ltd. regarding the development and legitimacy of their cord blood stem cell bank business. It addresses media doubts, explains the scientific and medical background, regulatory approvals, and operational status of the stem cell bank. There are no financial statements, no quarterly or annual financial data, no earnings highlights, no management or board changes, no voting results, no legal proceedings updates, and no mention of report attachments or filings. The document is a standalone company announcement clarifying business operations and addressing public concerns, which fits best under Regulatory Filings (RNS) as it does not match any other specific category such as Annual Report, Earnings Release, or Investor Presentation. The document length is about 4900 characters, which is substantial but not a formal report. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2001-11-26 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.